-
Pet’s Mesothelioma Leads to Remarkable Treatment Outcome
The asbestos that causes malignant mesothelioma in humans can also affect our furry friends, and dogs are notably vulnerable to the disease’s deadly tumors. When a six-year-old pet dog in Milan, Italy was diagnosed with mesothelioma of the pleura, pericardium and peritoneum, researchers took the opportunity to test an innovative drug delivery mechanism that loaded
-
Construction Supervisor Wins Multi-Million Dollar Mesothelioma Award
A former construction supervisor diagnosed with malignant mesothelioma was awarded over $15 million in damages by a California jury that agreed he had been exposed to asbestos in cement pipes. The jury assigned Norris Morgan and his wife compensatory damages of $15,270,501 and an additional $15 million in punitive damages, and though an appeals court
-
Study Examines “Real World” Treatment and Outcomes of Mesothelioma Patients
Though scientists around the world are investigating a wide range of innovative treatments for malignant mesothelioma, there is a gap between what happens in the laboratory and clinical trials and what is happening in community hospitals. A group of researchers set out to assess what happens in “real-world settings” in the United States and came
-
Iranian Company’s Appeal of $25 Million Mesothelioma Verdict Fails
Houshang and Soraya Sabetian filed a mesothelioma lawsuit against Fluor Enterprises and Middle East Fluor in 2018 after Houshang was diagnosed with the rare, testicular form of the disease. Houshang had worked for the companies from 1959 to 1979, while he was an Iranian citizen working for the National Iranian Oil Company in facilities that
-
UK Researcher Leverages Artificial Intelligence to Understand Mesothelioma
In the quest for a cure for malignant mesothelioma, scientists have long been at a considerable disadvantage. The rare form of asbestos-related cancer’s latency period allows it to grow within the body unnoticed for decades until it is extremely advanced, and traditional treatment approaches have proven insufficient. But researchers in the United Kingdom are leveraging
-
Minnesota Man’s Mesothelioma Lawsuit to be Heard in May
COVID-19 impacted many mesothelioma lawsuits, including the wrongful death claim filed by Carol Backe against Conwed Corporation. Though the trial was originally scheduled for February, its date was pushed back to May. The delay is one of many that the Backe family have faced since Gene “Randy” Backe was diagnosed with the fatal disease in
-
Researchers Confirm Role of PD-L1 in Peritoneal Mesothelioma
Malignant mesothelioma is one of the rarest cancers, with only about 3,500 people diagnosed with the disease in the United States each year. Of those 3,500, only about 20%, or 700 patients, are diagnosed with peritoneal mesothelioma, a form of the disease that impacts the lining of the peritoneal cavity. The extremely small number of
-
Phase Three Clinical Trial Opens for Mesothelioma Patient Enrollment
The greatest hope for extended survival in malignant mesothelioma lies in the development of new treatment protocols, but there’s a long road from innovation to approval. New drugs need to go through a rigorous clinical testing process that ensures both effectiveness and safety. One of the more promising treatments under review is the immunotherapy drug
-
UK Study Reveals Mesothelioma Patients Should Get 2nd COVID-19 Vaccine on Schedule
Mesothelioma patients and others diagnosed with cancer have spent the last year taking special precautions, avoiding contact with loved ones and others in order to protect against the risks of the coronavirus. Now several approved vaccines have promised an end to the danger, but a study is emphasizing the need for these patients to be
-
Acupuncture Study Delivers Useful News for Relief of Mesothelioma Pain
An eye-opening study conducted by researchers from the Memorial Sloan Kettering Cancer Center in New York provides welcome news on pain relief for mesothelioma patients. The research, published in the journal JAMA Oncology, shows that the use of acupuncture reduces chronic musculoskeletal pain in cancer survivors more effectively than traditional treatments, including pain medication, physical therapy and
-
Study of Electromagnetic Fields May Benefit Mesothelioma Patients
A study of electromagnetic fields and their effect on cancer metastasis specifically focused on breast cancer cells, but its authors believe that the technology may have an impact on many types of highly metastatic cancers, including malignant mesothelioma. The research was conducted by scientists from the department of mechanical and aerospace engineering at The Ohio
-
Mesothelioma Blamed on Gloves and Boards Used While Making Stained Glass
There are many industries and jobs that are traditionally associated with exposure to asbestos – and subsequently with a mesothelioma diagnosis – but making stained glass is not an occupation that immediately comes to mind. Still, according to Michael A. Love’s survivors, his career in the stained-glass industry put him in direct contact with asbestos
-
Researchers Study Pandemic’s Impact on Screening for Mesothelioma and Other Cancers
Though the pandemic is not yet fully in the rear-view mirror, the availability of three different vaccines is making a big difference, especially for those at risk for malignant mesothelioma. The elderly men and women with a history of exposure to asbestos are among the first group to be eligible for immunizations, and once they
-
Is Minimally Invasive Mesothelioma Surgery a Possibility?
When it comes to surgery for malignant mesothelioma, patients have few options. The procedure is generally done for either curative purposes – to remove as much cancerous tissue as possible in order to prolong life – or palliative purposes, to remove enough of the disease’s tumors to provide relief from pressure on organs and improve
-
Maryland Mesothelioma Victims See Chance for Compensation Diminished
A multi-year backlog of lawsuits against asbestos product companies is being winnowed down as many cases are being dropped or dismissed, leaving victims of mesothelioma, asbestosis, and other serious diseases with little recourse and high levels of frustration. The unfortunate outcome follows refusal on the part of legislators and the judiciary to agree to consolidating
-
Study Criticizes Selective Use of Data Regarding Asbestos Dangers
A recently published study published in the Journal of Occupational Medicine and Toxicology highlights the challenges faced by those trying to link asbestos exposure to malignant mesothelioma. According to two noted experts in environmental and occupational health, asbestos industry lobbyists selectively use data and disinformation to minimize the mineral’s risks.
-
Former Boilermaker Seeking $27 Million in Compensation for Mesothelioma
A Seattle jury heard closing arguments this week in a mesothelioma lawsuit that pitted a former boilermaker against Pryor Giggey, Co. The victim’s attorney built a case showing that the company had manufactured asbestos-contaminated boiler refractory insulation to which Cliff Little had been exposed while working at Puget Sound Naval Shipyard.
-
Improper Witness Testimony Leads to Mesothelioma Retrial
A recent mesothelioma lawsuit accused Johnson & Johnson and Colgate-Palmolive of negligently allowing their talcum powder products to be contaminated with asbestos, leading to the untimely death of Donna Hayes. Though the jury found the companies blameless, Mrs. Hayes’ family appealed that decision on the basis of improper witness testimony that they’d unsuccessfully tried to
-
FDG-PET Radiomic Modeling Helps Predict Mesothelioma Outcomes
With the help of advanced imaging techniques and computer modeling, Swiss physicians believe that they’ve found a more effective way of predicting the progression of pleural mesothelioma tumors. Their innovation combines the power of FDG-PET scans and advanced computer programming.
-
Retrospective Study Confirms Superiority of Less Aggressive Mesothelioma Surgery
Patients facing the grim outlook of a malignant pleural mesothelioma diagnosis are faced with a series of difficult treatment decision. Among the most challenging is whether to undergo an extremely aggressive form of surgery that sacrifices one of their lungs or a less aggressive-but-easier-to-tolerate procedure that leaves their lung and much of their thoracic tissue
